Importantly, the design of our study likely underestimates the incidental number of BKCa-DEC positive BC, as (i) only hormone-receptor positive BC specimens were included, and (ii) bulk-tumor mRNA was analyzed, hampering the detection of low-abundant or tightly regulated transcripts against a strong background of non-cancer cells present in bulk tumor tissues. This evidence concerns the gene NR4A1 and cancer.